Independent equity research
Is AXA S.A. (AXA) a Buy, Hold or Sell?
AXA S.A. — our independent, AI-built valuation and rating, in brief.
BUY (accumulate)
12-mo fair value
€49.00
To fair value
+13%
By · report dated 2026-09-02 · fair value derived independently of the market price.
The thesis, in brief
The market prices AXA at 9.7 times 2027 earnings, a fifth below its peers, for AXA XL casualty risk and French sovereign risk already charged in our beta and country premium; we are wrong if AXA XL strengthens prior-year reserves or the 15 September plan cuts the 6-8% growth ambition
How we value it
We value AXA S.A. using Excess return on IFRS equity, cross-checked by peer forward P/E and a segment sum-of-the-parts. The 12-month fair value is set from that intrinsic estimate first, then compared to the market to read the upside or downside — never anchored to the current price.
What the full report covers
- Business & moat + industry cycle
- Earnings quality & normalized EPS
- Returns on capital (ROIC vs WACC)
- Balance-sheet safety
- Two independent valuations (DCF + multiples)
- Bear / base / bull fair values
- Earnings-call analysis
- Insider activity & positioning
- Technicals (RSI / ADX)
- A falsifiable thesis
Read the full AXA S.A. report
The complete model, the scenarios, and every number behind the call — plus other names across the coverage. One subscription, cancel anytime.